Dietary intake and cardiovascular outcomes in patients with chronic vascular disease: insights from the COMPASS trial cohort.

AIMS Patients with coronary artery disease (CAD) and patients with peripheral artery disease (PAD) are at risk for major adverse cardiovascular events (MACE) and major adverse limb events (MALE). There are limited data regarding dietary patterns and the risk of recurrent MACE and MALE in CAD and PAD patients. We aimed to identify dietary patterns associated with MACE and MALE in patients with CAD and/or PAD. METHODS AND RESULTS We analysed data collected from patients enrolled into the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) trial, in which diet was assessed by a short food frequency questionnaire (FFQ) at baseline. Two dietary pattern scores, the modified Alternate Healthy Eating Index (mAHEI) and Mediterranean Diet Score (mMDS), were calculated. We tested the association between mAHEI and mMDS and the incidence of MACE and/or MALE. The mean mAHEI score was 23.0 ± 7.7 (out of 70) overall and was similar comparing CAD and PAD patients. The incidence of MACE or MALE was 6.3% in the lowest diet quality quartile (as assessed by mAHEI) compared with 4.2% in the highest quartile over 30 months. In the fully adjusted model, the hazard ratio of a low diet quality (Quartile 1) compared with the highest (Quartile 4) for MACE or MALE was 1.27 (95% CI: 1.08-1.49; P = 0.004, Q1 vs. Q4). This excess hazard was primarily driven by higher MACE in both the CAD and PAD cohorts. CONCLUSIONS Poor diet quality as assessed by the mAHEI is independently associated with a higher risk of recurrent MACE and MALE in patients with chronic CAD and/or PAD.

[1]  L. Banfield,et al.  Diet and Nutrition in Peripheral Artery Disease: A Systematic Review. , 2022, The Canadian journal of cardiology.

[2]  Deepak L. Bhatt,et al.  Abstract 10627: Benefits of Icosapent Ethyl in Patients with Prior Peripheral Artery Disease: REDUCE-IT PAD , 2021, Circulation.

[3]  T. Kodama,et al.  Optimal cut-off value of preprocedural geriatric nutritional risk index for predicting the clinical outcomes of patients undergoing endovascular revascularization for peripheral artery disease. , 2020, Journal of cardiology.

[4]  J. Manson,et al.  Association Between Healthy Eating Patterns and Risk of Cardiovascular Disease. , 2020, JAMA internal medicine.

[5]  A. Guntani,et al.  Preoperative Nutritional Status is an Independent Predictor of the Long-term Outcome in Patients Undergoing Open Bypass for Critical Limb Ischemia. , 2020, Annals of vascular surgery.

[6]  A. Guntani,et al.  Impact of the Geriatric Nutritional Risk Index on the Long-Term Outcomes of Patients Undergoing Open Bypass for Intermittent Claudication. , 2019, Circulation journal : official journal of the Japanese Circulation Society.

[7]  F. Bäckhed,et al.  Intestinal Microbiota in Cardiovascular Health and Disease: JACC State-of-the-Art Review. , 2019, Journal of the American College of Cardiology.

[8]  Deepak L. Bhatt,et al.  Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia , 2019, The New England journal of medicine.

[9]  M. Martínez-González Protocol Deviations, Reanalyses, and Corrections to PREDIMED Trial Derivative Study on Peripheral Artery Disease. , 2018, JAMA.

[10]  D. Mozaffarian,et al.  Association of dairy intake with cardiovascular disease and mortality in 21 countries from five continents (PURE): a prospective cohort study , 2018, The Lancet.

[11]  M. Hernán,et al.  Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra‐Virgin Olive Oil or Nuts , 2018, The New England journal of medicine.

[12]  Deepak L. Bhatt,et al.  Major Adverse Limb Events and Mortality in Patients With Peripheral Artery Disease: The COMPASS Trial. , 2018, Journal of the American College of Cardiology.

[13]  Marc P. Bonaca,et al.  Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk) , 2017, Circulation.

[14]  Khalid Yusoff,et al.  Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial. , 2017, Lancet.

[15]  L. Schwingshackl,et al.  Diet Quality as Assessed by the Healthy Eating Index, Alternate Healthy Eating Index, Dietary Approaches to Stop Hypertension Score, and Health Outcomes: An Updated Systematic Review and Meta-Analysis of Cohort Studies. , 2017, Journal of the Academy of Nutrition and Dietetics.

[16]  Deepak L. Bhatt,et al.  Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease , 2017, The New England journal of medicine.

[17]  Deepak L. Bhatt,et al.  Rationale, Design and Baseline Characteristics of Participants in the Cardiovascular Outcomes for People Using Anticoagulation Strategies (COMPASS) Trial. , 2017, The Canadian journal of cardiology.

[18]  P. Gurbel,et al.  Ticagrelor versus Clopidogrel in Peripheral Artery Disease. , 2017, The New England journal of medicine.

[19]  D. Corella,et al.  Association of Mediterranean diet with peripheral artery disease: the PREDIMED randomized trial. , 2014, JAMA.

[20]  S. Yusuf,et al.  Relationship Between Healthy Diet and Risk of Cardiovascular Disease Among Patients on Drug Therapies for Secondary Prevention: A Prospective Cohort Study of 31 546 High-Risk Individuals From 40 Countries , 2012, Circulation.

[21]  R. de Caterina,et al.  Nutritional mechanisms that influence cardiovascular disease. , 2006, The American journal of clinical nutrition.

[22]  W. Willett,et al.  Evaluating adherence to recommended diets in adults: the Alternate Healthy Eating Index , 2006, Public Health Nutrition.

[23]  Tina Costacou,et al.  Adherence to a Mediterranean diet and survival in a Greek population. , 2003, The New England journal of medicine.

[24]  Donna Spiegelman,et al.  Diet quality and major chronic disease risk in men and women: moving toward improved dietary guidance. , 2002, The American journal of clinical nutrition.

[25]  Jean-Louis Martin,et al.  Mediterranean Diet, Traditional Risk Factors, and the Rate of Cardiovascular Complications After Myocardial Infarction Final Report of the Lyon Diet Heart Study , 1999 .

[26]  J. Bosch,et al.  Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial. , 2018, Lancet.

[27]  A Ross Naylor,et al.  2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed b , 2018, European heart journal.

[28]  L. Fleisher,et al.  2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2017, Journal of the American College of Cardiology.